Authors:
CHAUFOUR S
LECOZ F
DENOLLE T
DUBRUC C
CIMAROSTI I
DESCHAMPS C
ULLIAC N
DELHOTALLANDES B
ROSENZWEIG P
Citation: S. Chaufour et al., LACK OF EFFECT OF MIZOLASTINE ON THE SAFETY AND PHARMACOKINETICS OF DIGOXIN ADMINISTERED ORALLY IN REPEATED DOSES TO HEALTHY-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 36(5), 1998, pp. 286-291
Authors:
ROSENZWEIG P
PATAT A
ZIELENIUK I
CIMAROSTI I
ALLAIN H
GANDON JM
Citation: P. Rosenzweig et al., COGNITIVE PERFORMANCE IN ELDERLY SUBJECTS AFTER A SINGLE-DOSE OF BEFLOXATONE, A NEW REVERSIBLE SELECTIVE MONOAMINE-OXIDASE-A INHIBITOR, Clinical pharmacology and therapeutics, 64(2), 1998, pp. 211-222
Authors:
PATAT A
DUBRUC C
DESCHAMP C
DURRIEU G
TROCHERIE S
CIMAROSTI I
ALLAIN H
ROSENZWEIG P
GANDON JM
Citation: A. Patat et al., EEG, MAO-A INHIBITION, PHARMACOKINETICS AND SAFETY OF BEFLOXATONE IN THE ELDERLY, Human psychopharmacology, 12(6), 1997, pp. 557-571
Citation: E. Souetre et al., PREDICTING FACTORS FOR ABSENTEEISM IN PATIENTS WITH MAJOR DEPRESSIVE-DISORDERS, European journal of epidemiology, 13(1), 1997, pp. 87-93
Authors:
DENOLLE T
ALBERINI H
TURBIN A
CIMAROSTI I
PATAT A
GANDON JM
Citation: T. Denolle et al., DEFINITION OF BASE-LINE BLOOD-PRESSURE IN NORMOTENSIVE VOLUNTEERS, Archives des maladies du coeur et des vaisseaux, 90(8), 1997, pp. 1097-1101
Authors:
PATAT A
LECOZ F
DUBRUC C
GANDON JM
DURRIEU G
CIMAROSTI I
JEZEQUEL S
CURET O
ZIELENIUK I
ALLAIN H
ROSENZWEIG P
Citation: A. Patat et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF 2 DOSE REGIMENS OF BEFLOXATONE, A NEW REVERSIBLE AND SELECTIVE MONOAMINE-OXIDASE INHIBITOR, AT STEADY-STATE IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(3), 1996, pp. 216-229
Authors:
PATAT A
GANDON JM
DURRIEU G
LECOZ F
CURET O
CIMAROSTI I
ALLAIN H
Citation: A. Patat et al., EFFECTS OF SINGLE AND MULTIPLE DOSES OF A NEW REVERSIBLE MAO-A INHIBITOR, BEFLOXATONE, ON PSYCHOMOTOR PERFORMANCE AND MEMORY IN HEALTHY-SUBJECTS, Human psychopharmacology, 10(2), 1995, pp. 111-125